Bicycle Therapeutics
IPO News: Bicycle Therapeutics Prices 4.3mm Share IPO at $14, at the bottom of the $14.00 - $16.00 Marketing Range
Bicycle Therapeutics

Bicycle Therapeutics

NASDAQ: BCYC

Initial Filing Date: 04/26/19

Launch Date: 05/13/19

Pricing Date: 05/22/19

IPO Price: $14.00

Price Range: $14.00 - $16.00

Shares Offered (Pre-Shoe | mm): 4.33

Primary Shares (mm): 4.33

Secondary Shares (mm): 0.00

Amount Offered (mm): $60.7

% Secondary: 0.0%

Shares Outstanding (mm): 17.7

Market Value at Pricing (mm): $247.7

Offering as % of Market Value: 24.5%

Bookrunners: GS | JEFF | PJ | CCG

Major Holders:   Atlas Venture Fund | Novartis Bioventures | S.R One Limited | SVLS Life Sciences | Vertex Global Healthcare | Cambridge Innovation Capital | Longwood Fund | Ahren Innovation Capital Holding Limited | Tybourne Capital Management  

Industry: Healthcare

Description: Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, which they refer to as Bicycles, for diseases that are underserved by existing therapeutics.

Note: Emerging Growth Company

Reference Link: Press release